Treasurer of the State of North Carolina
APLS

Treasurer of the State of North Carolina’s Apellis Pharmaceuticals APLS Stock Holding History

Treasurer of the State of North Carolina’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,153
Closed -$1.86M – 1099
2026
Q1 		$1.86M Buy
46,153
+983
+2% +$21.2K 0.01% 861
2025
Q4 		$1.14M Sell
45,170
-3,296
-7% -$77.3K ﹤0.01% 933
2025
Q3 		$1.1M Sell
48,466
-1,892
-4% -$44.1K ﹤0.01% 963
2025
Q2 		$872K Buy
50,358
+1,353
+3% +$25K ﹤0.01% 988
2025
Q1 		$1.07M Buy
49,005
+3,090
+7% +$85.4K ﹤0.01% 946
2024
Q4 		$1.47M Buy
45,915
+290
+0.6% +$8.72K 0.01% 913
2024
Q3 		$1.32M Buy
45,625
+180
+0.4% +$6.67K 0.01% 938
2024
Q2 		$1.74M Buy
45,445
+315
+0.7% +$14.3K 0.01% 884
2024
Q1 		$2.65M Buy
45,130
+310
+0.7% +$19.8K 0.01% 790
2023
Q4 		$2.68M Buy
44,820
+1,020
+2% +$51.7K 0.01% 773
2023
Q3 		$1.67M Buy
43,800
+230
+0.5% +$10.1K 0.01% 874
2023
Q2 		$3.97M Buy
+43,570
New +$3.76M 0.02% 606

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Treasurer of the State of North Carolina's APLS Position: Q2 2026 in Review

Treasurer of the State of North Carolina sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 46,153 shares — an estimated $1.86M sold.

Treasurer of the State of North Carolina first reported a position in APLS in Q2 2023 and held it in 12 quarters. The position peaked at $3.97M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Treasurer of the State of North Carolina reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 46,153 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.86M.
  • Treasurer of the State of North Carolina first reported a position in Apellis Pharmaceuticals in Q2 2023 and held it in 12 quarters.
  • Treasurer of the State of North Carolina's Apellis Pharmaceuticals position peaked at $3.97M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.